Market Place
Sourcing Support
Eli Lilly And’s Foundayo Receives Approval in US
01 Apr 2026 //
FDA
Eli Lilly’s Jaypirca Approved in Canada
17 Oct 2025 //
HEALTH CANADA
Eli Lilly`s Inluriyo Receives Approval in US
25 Sep 2025 //
FDA
Eli Lilly’s Kisunla Receives Approval In Europe
24 Sep 2025 //
EMA
Lilly’s Biologics Humatrope Receives Suppl Approval in US
09 Jul 2025 //
FDA
Eli Lilly`s Biologics Kisunla Receive Suppl Approval in US
01 Jul 2025 //
FDA
Eli Lilly`s Biologics Ebglyss Receives Suppl Approval in US
22 May 2025 //
FDA
Eli Lilly`s Biologic Cyramza Receives Suppl Approval in US
07 Apr 2025 //
FDA
Eli lilly`s Biologic Omvoh Receives Suppl Approval in US
15 Jan 2025 //
FDA
Avid Radiopharm`s Tauvid (flortaucipir (18F)) Receives Approval in Europe
22 Aug 2024 //
EMA
Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Suppl Approvals in US
19 Aug 2024 //
FDA
Eli Lilly`s Biologic Humatrope (somatropin) Receives Approval in the U.S.
08 Dec 2023 //
FDA
Eli Lilly`s Jaypirca (pirtobrutinib) Receives Approval in Europe
20 Nov 2023 //
EMA
Eli Lilly`s Mounjaro (tirzepatide) Receives Approval in Europe
26 Oct 2023 //
EMA
Eli Lilly`s Biologic Taltz (Ixekizumab) Receives Approval in the U.S.
13 Sep 2023 //
FDA
Lilly`s Biologic Humalog (Insulin Lispro) Receives Approval in the U.S.
21 Jul 2023 //
FDA
Eli Lilly`s Retsevmo (selpercatinib) Receives Approval in Europe
18 Jul 2023 //
EMA
Eli Lilly`s Omvoh (Mirikizumab) Receives Approval in Europe
08 Jun 2023 //
EMA
Eli Lilly`s Mounjaro (Tirzepatide) Receives Approval in the Europe
25 Nov 2022 //
EMA
Eli Lilly`s Biologic Trulicity (Dulaglutide) Receives Approval in the U.S.
17 Nov 2022 //
FDA
Eli Lilly`s Biologic Rezvoglar (Glargine) Receives Approval in the U.S.
16 Nov 2022 //
FDA
Eli Lilly`s Biologic Lyumjev (Insulin Lispro) Receives Approval in the U.S.
15 Oct 2022 //
FDA
Eli Lilly`s Rayvow (lasmiditan) Receives Approval in Europe
03 Oct 2022 //
EMA
Eli Lilly`s Taltz(Ixekizumab) Receives BLA Approval in the U.S.
27 Jul 2022 //
FDA
Eli Lilly Generic Dulaglutide Receives Approval in the U.S.
10 Jun 2022 //
FDA
Eli Lilly Taltz (Ixekizumab) Receives Supplemental Approval in the U.S.
04 May 2022 //
FDA
Eli Lilly`s Biologic Cyramza (Ramucirumab) Receives Approval in the U.S.
22 Mar 2022 //
FDA
Eli Lilly`s Biological Dulaglutide Receives Supplemental Approval In US
30 Sep 2021 //
FDA
Eli Lilly`s Biological Ramucirumab Receives Supplemental Approval In US
17 Jun 2021 //
FDA
Eli lilly`s biological Trulicity (Dulaglutide) Receives Approval In The US
13 Sep 2020 //
FDA
Eli Lilly`s Cyramza (Ramucirumab) Receives Supplemental Approval in US
08 Jul 2020 //
FDA
Eli Lilly`s Taltz (Ixekizumab) Receives Supplemental Approval in US
31 Mar 2020 //
FDA
Eli Lilly`s Trulicity (Dulaglutide) Receives Supplemental Approval in US
24 Feb 2020 //
FDA
Eli Lilly`s Cyramza (Ramucirumab) Receives Supplemental Approval in US
07 Nov 2019 //
FDA
Eli Lilly`s Taltz (Ixekizumab) Receives Supplemental Approval in US
28 Aug 2019 //
FDA
Eli Lilly`s Cyramza (Ramucirumab) Receives Supplemental Approval in US
03 Aug 2019 //
FDA
Eli Lilly`s Cyramza (Ramucirumab) Receives Supplimental Approval In US
13 May 2019 //
FDA
Eli Lilly`s Dulaglutide Receives Supplemental Approval in US
15 Jan 2019 //
FDA
Eli Lilly`s Ramucirumab Receives Supplemental Approval in US
28 Nov 2018 //
FDA
Eli Lilly`s Biological Ramucirumab Receives Approval in US
26 Nov 2018 //
FDA
Eli Lilly`s Verzenios (abemaciclib) Receives Approval in Europe
30 Oct 2018 //
EMA
Eli Lilly`s Biological Cymraza (Ramucirumab) Receives Approval in US
17 Aug 2018 //
FDA
Eli Lilly`s Biological Lartruvo (Olaratumab) Receives Approval in US
14 Aug 2018 //
FDA
Eli Lilly And Co.’s Generic Dulaglutide Receives Approval in the US
03 Jul 2018 //
FDA
Eli Lilly And Co Taltz (Ixekizumab) Receives Supplemental Approval In US
22 May 2018 //
FDA
Eli Lilly’s Trulicity (Dulaglutide ) Receives Supplemental Approval In US
03 Aug 2017 //
FDA
Eli Lilly’s Taltz Ixekizumab Receives Supplemental Approval In US
07 Jul 2017 //
FDA
Eli Lilly Nederland Tadalafil Lilly (tadalafil) Receives Approval In Europe
10 Apr 2017 //
EMA
Eli Lilly Nederland Olumiant (Baricitinib) Receives Approval In Europe
16 Mar 2017 //
EMA
Eli Lilly`s Supplement Trulicity (Dulaglutide) Receives Approval In US
27 Jan 2017 //
FDA
Eli Lilly And Co`s Humalog Kwikpen Receives Approval In US
06 Jan 2017 //
FDA
Eli Lilly`s Humalog Mix 50/50 Receives Approval In US
06 Jan 2017 //
FDA
Eli Lilly`s Humalog Pen Receives Approval In US
06 Jan 2017 //
FDA
